[HTML][HTML] How to contain artemisinin-and multidrug-resistant falciparum malaria
AM Dondorp, FM Smithuis, C Woodrow… - Trends in …, 2017 - cell.com
In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
[PDF][PDF] How to Contain Artemisinin-and Multidrug-Resistant Falciparum Malaria
AM Dondorp, FM Smithuis, C Woodrow… - Trends in …, 2017 - academia.edu
In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
How to Contain Artemisinin-and Multidrug-Resistant Falciparum Malaria
AM Dondorp, FM Smithuis, C Woodrow… - Trends in …, 2017 - infona.pl
In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
How to contain artemisinin-and multidrug-resistant falciparum malaria.
AM Dondorp, FM Smithuis, C Woodrow, L Seidlein - 2017 - cabidigitallibrary.org
Abstract In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly
compounded by partner drug resistance, causing high failure rates of artemisinin …
compounded by partner drug resistance, causing high failure rates of artemisinin …
How to Contain Artemisinin-and Multidrug-Resistant Falciparum Malaria.
AM Dondorp, FM Smithuis, C Woodrow… - Trends in …, 2017 - europepmc.org
In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
[HTML][HTML] How to Contain Artemisinin-and Multidrug-Resistant Falciparum Malaria
AM Dondorp, FM Smithuis, C Woodrow… - Trends in …, 2017 - Elsevier
In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
[PDF][PDF] How to Contain Artemisinin-and Multidrug-Resistant Falciparum Malaria
AM Dondorp, FM Smithuis, C Woodrow… - Trends in …, 2017 - scholar.archive.org
In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
How to Contain Artemisinin-and Multidrug-Resistant Falciparum Malaria
AM Dondorp, FM Smithuis, C Woodrow… - Trends in …, 2017 - pubmed.ncbi.nlm.nih.gov
In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
[PDF][PDF] How to Contain Artemisinin-and Multidrug-Resistant Falciparum Malaria
AM Dondorp, FM Smithuis, C Woodrow, L von Seidlein - 2017 - cyberleninka.org
In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
How to contain artemisinin-and multidrug-resistant Falciparum malaria
A Dondorp, F Smithuis, C Woodrow… - Trends in …, 2017 - ora.ox.ac.uk
In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …